Evidence 1
Activity
Activity
12% Hemolysis
Toxicity
62.54 µM
Hemolytic
Cytotoxic
12% Hemolysis | 62.54 | µM | target cell: Human erythrocytes
Target
Human erythrocytes
Source & Reference
NA
DBAASP
Anticancer Activities of Antimicrobial BmKn2 Peptides Against Oral and Colon Cancer Cells | Int J Pept Res Ther | 2014